This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Gallo JM , Brennan J , Hamilton TC , Halbherr T , Laub PB , Ozols RF , Odwyer PJ
Time-Dependent Pharmacodynamic Models in Cancer-Chemotherapy - Population Pharmacodynamic Model for Glutathione Depletion Following Modulation by Buthionine Sulfoximine (Bso) in a Phase-I Trial of Melphalan and Bso
Cancer Research. 1995 Oct 15;55(20) :4507-4511
AbstractThe development of time-dependent pharmacodynamic models in cancer chemotherapy has been extremely limited, A population approach was used to develop such a model to describe the effect of buthionine sulfoximine (BSO), via its active S-isomer (S-BSO), on glutathione (GSH) depletion in peripheral mononuclear cells. The Phase I trial utilized escalating doses of BSO, from 5 to 17 gm/m(2), as a multiple infusion regimen, The population model consisted of a linear 2-compartment pharmacokinetic model coupled to an indirect response model, The indirect response model consisted of a GSH compartment with input and output rate processes that are modulated as a function of S-BSO and GSH concentrations, The model predicted the observed gradual depletion of GSH, a nadir at approximately 30 h after the last dose of BSO, and a return to baseline GSH levels, On the basis of an IC50 estimate of about 1.6 mu M for inhibition of gamma-glutamylcysteine synthetase, the target enzyme of BSO, the population model predicted near identical GSH concentration time profiles over the dose range studied. Time-dependent pharmacodynamic models are seen as a powerful means to design dosing regimens and to provide a mathematical platform for mechanistic based models.
NotesTimes Cited: 16 Note RZ069 CANCER RES